IHE iShares U.S. Pharmaceuticals ETF

USD 67.90 0.20 0.288035
Icon

iShares U.S. Pharmaceuticals ETF (IHE) Stock Analysis and Price Targets

ETF | Health | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 67.90

+0.20 (+0.29)%

USD 0.64B

0.03M

N/A

N/A

Icon

IHE

iShares U.S. Pharmaceuticals ETF (USD)
ETF | NYE
USD 67.90
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.64B

N/A

USD 67.90

iShares U.S. Pharmaceuticals ETF (IHE) Stock Forecast

N/A

Based on the iShares U.S. Pharmaceuticals ETF stock forecast from 0 analysts, the average analyst target price for iShares U.S. Pharmaceuticals ETF is not available over the next 12 months. iShares U.S. Pharmaceuticals ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares U.S. Pharmaceuticals ETF is Neutral, which is based on 3 positive signals and 3 negative signals. At the last closing, iShares U.S. Pharmaceuticals ETF’s stock price was USD 67.90. iShares U.S. Pharmaceuticals ETF’s stock price has changed by +1.08% over the past week, -66.99% over the past month and +17.52% over the last year.

No recent analyst target price found for iShares U.S. Pharmaceuticals ETF
No recent average analyst rating found for iShares U.S. Pharmaceuticals ETF

Company Overview iShares U.S. Pharmaceuticals ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures ...Read More

http://www.ishares.com

N/A

N/A

N/A

USD

USA

01/05/2006

DJ US Select Pharms TR USD

MSCI ACWI NR USD

0.40 %

Adjusted Closing Price for iShares U.S. Pharmaceuticals ETF (IHE)

Loading...

Unadjusted Closing Price for iShares U.S. Pharmaceuticals ETF (IHE)

Loading...

Share Trading Volume for iShares U.S. Pharmaceuticals ETF Shares

Loading...

Compare Performance of iShares U.S. Pharmaceuticals ETF Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for IHE

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 3

  • MSCI ACWI NR USD

  • 3

  • 14.34

  • 0.00

  • 0.30

  • 9.11%

  • 5.84%

  • 7.21%

  • 0%

Stocks Similar To iShares U.S. Pharmaceuticals ETF (Sector: Health )

Symbol Name Mer Price(Change) Market Cap
XLV
Health Care Select Sector SPDR.. 0.09 % +0.02 (+0.01%) USD40.87B

ETFs Containing IHE

Symbol Name IHE's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About iShares U.S. Pharmaceuticals ETF (IHE) Stock

Stock Target Advisor's fundamental analysis for iShares U.S. Pharmaceuticals ETF's stock is Neutral.

IHE stock's dividend yield is 1.35%. Our analysis grades IHE stock's dividend yield at B+. This means that IHE stock's dividend yield is above 89% of the stocks in the Health sector in the NYE exchange. Based on this IHE may be a good dividend stock for its sector.

Unfortunately we do not have enough data on IHE's stock to indicate what its average analyst target is.

IHE stock's Price/Earning ratio is 25.50. Our analysis grades IHE stock's Price / Earning ratio at F. This means that IHE stock's Price/Earning ratio is above 75% of the stocks in the Health sector in the NYE exchange. Based on this IHE may be a overvalued for its sector.

The last closing price of IHE's stock was USD 67.90.

The most recent market capitalization for IHE is USD 0.64B.

Unfortunately we do not have enough analyst data on IHE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains iShares U.S. Pharmaceuticals ETF's stock.

Sorry, we do not have any data on the number of employees for iShares U.S. Pharmaceuticals ETF.

Sorry we do not have any infomation available on iShares U.S. Pharmaceuticals ETF's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...